Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer

被引：0
|
作者：
Fara Brasó-Maristany
Simone Filosto
Steven Catchpole
Rebecca Marlow
Jelmar Quist
Erika Francesch-Domenech
Darren A Plumb
Leila Zakka
Patrycja Gazinska
Gianmaria Liccardi
Pascal Meier
Albert Gris-Oliver
Maggie Chon U Cheang
Anna Perdrix-Rosell
Manar Shafat
Elodie Noël
Nirmesh Patel
Kristen McEachern
Maurizio Scaltriti
Pau Castel
Farzana Noor
Richard Buus
Sumi Mathew
Johnathan Watkins
Violeta Serra
Pierfrancesco Marra
Anita Grigoriadis
Andrew N Tutt
机构：
来源：
Nature Medicine | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nat. Med. 22, 1303–1313 (2016); published online 24 October 2016; corrected after print 26 January 2017 In the version of this article initially published, the western blot in Figure 2a for the BT474 cell line was incorrect. In addition, one of the accession codes for gene expression data for the Guy's Hospital TNBC-enriched cohort was incorrect.
引用
收藏
页码：526 / 526
相关论文
共 50 条
  • [21] Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer
    Cynthia Villarreal-Garza
    Daniel Khalaf
    Nathaniel Bouganim
    Mark Clemons
    Omar Peña-Curiel
    Berenice Baez-Revueltas
    Alexander Kiss
    Farah Kassam
    Katherine Enright
    Sunil Verma
    Kathleen Pritchard
    Jeff Myers
    Rebecca Dent
    Breast Cancer Research and Treatment, 2015, 150 : 697 - 697
  • [22] Effect of tumor microenvironment on chemotherapy response of patients with triple-negative breast cancer receiving neoadjuvant chemotherapy
    Kim, Jae-Joon
    Kim, Dongjin
    Yu, Yeuni
    Jung, Ki Sun
    Kim, Yun Hak
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Inhibition of death-associated protein kinase 1 enhances chemotherapy action against triple-negative breast cancer
    Zhao, D.
    Zhao, J.
    Mazumadar, A.
    Bollu, L.
    Shepherd, J.
    Ma, Y.
    Zhang, Y.
    Hill, J. L.
    Savage, M. I.
    Brown, P. H.
    CANCER RESEARCH, 2017, 77
  • [24] PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Sutapa Mahata
    Pranab K. Sahoo
    Ranita Pal
    Sinjini Sarkar
    Tanuma Mistry
    Sushmita Ghosh
    Vilas D. Nasare
    Medical Oncology, 39
  • [25] PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Mahata, Sutapa
    Sahoo, Pranab K.
    Pal, Ranita
    Sarkar, Sinjini
    Mistry, Tanuma
    Ghosh, Sushmita
    Nasare, Vilas D.
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [26] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono
    Hitoshi Tsuda
    Chikako Shimizu
    Sohei Yamamoto
    Tatsuhiro Shibata
    Harukaze Yamamoto
    Taizo Hirata
    Kan Yonemori
    Masashi Ando
    Kenji Tamura
    Noriyuki Katsumata
    Takayuki Kinoshita
    Yuichi Takiguchi
    Hideki Tanzawa
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2012, 132 : 793 - 805
  • [27] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, Makiko
    Tsuda, Hitoshi
    Shimizu, Chikako
    Yamamoto, Sohei
    Shibata, Tatsuhiro
    Yamamoto, Harukaze
    Hirata, Taizo
    Yonemori, Kan
    Ando, Masashi
    Tamura, Kenji
    Katsumata, Noriyuki
    Kinoshita, Takayuki
    Takiguchi, Yuichi
    Tanzawa, Hideki
    Fujiwara, Yasuhiro
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 793 - 805
  • [28] CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer
    Black, Justin L.
    Harrell, J. Chuck
    Leisner, Tina M.
    Fellmeth, Melissa J.
    George, Samuel D.
    Reinhold, Dominik
    Baker, Nicole M.
    Jones, Corbin D.
    Der, Channing J.
    Perou, Charles M.
    Parise, Leslie V.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (02) : 337 - 346
  • [29] CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer
    Justin L. Black
    J. Chuck Harrell
    Tina M. Leisner
    Melissa J. Fellmeth
    Samuel D. George
    Dominik Reinhold
    Nicole M. Baker
    Corbin D. Jones
    Channing J. Der
    Charles M. Perou
    Leslie V. Parise
    Breast Cancer Research and Treatment, 2015, 152 : 337 - 346
  • [30] Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
    Anurag, Meenakshi
    Jaehnig, Eric J.
    Krug, Karsten
    Lei, Jonathan T.
    Bergstrom, Erik J.
    Kim, Beom-Jun
    Vashist, Tanmayi D.
    Huynh, Anh Minh Tran
    Dou, Yongchao
    Gou, Xuxu
    Huang, Chen
    Shi, Zhiao
    Wen, Bo
    Korchina, Viktoriya
    Gibbs, Richard A.
    Muzny, Donna M.
    Doddapaneni, Harshavardhan
    Dobrolecki, Lacey E.
    Rodriguez, Henry
    Robles, Ana I.
    Hiltke, Tara
    Lewis, Michael T.
    Nangia, Julie R.
    Shafaee, Maryam Nemati
    Li, Shunqiang
    Hagemann, Ian S.
    Hoog, Jeremy
    Lim, Bora
    Osborne, C. Kent
    Mani, D. R.
    Gillette, Michael A.
    Zhang, Bing
    Echeverria, Gloria V.
    Miles, George
    Rimawi, Mothaffar F.
    Carr, Steven A.
    Ademuyiwa, Foluso O.
    Satpathy, Shankha
    Ellis, Matthew J.
    CANCER DISCOVERY, 2022, 12 (11) : 2586 - 2605
12345